US Patent Issued to UCB BIOPHARMA on July 15 for "Substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator" (Belgian Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,890, issued on July 15, was assigned to UCB BIOPHARMA SRL (Brussels).

"Substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator" was invented by Anne Valade (Brussels).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds according to formula (I), which are a positive allosteric modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role."

The patent was filed on June 29, 2020, under Application No. 17/621,871.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netac...